Citadel Advisors’s Peak Bio, Inc. Warrant PKBOW Stock Holding History

Citadel Advisors’s Portfolio PKBOW Stock Details PKBOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-15,782	Closed	-$2K	–	15794
2022 Q3	$2K	Buy	15,782 +893	+6%	+$154	﹤0.01%	12436
2022 Q2	$3K	Sell	14,889 -1,195	-7%	-$383	﹤0.01%	12716
2022 Q1	$6K	Buy	16,084 +795	+5%	+$340	﹤0.01%	13420
2021 Q4	$12K	Hold	15,289	–	–	﹤0.01%	13658
2021 Q3	$10K	Sell	15,289 -37,500	-71%	-$29.8K	﹤0.01%	13687
2021 Q2	$41K	Hold	52,789	–	–	﹤0.01%	13410
2021 Q1	$48K	Buy	+52,789	New	+$59.4K	﹤0.01%	12926

Other funds holding PKBOW

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

EFI

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.95% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Citadel Advisors's PKBOW Position: Q4 2022 in Review

Citadel Advisors sold out of Peak Bio, Inc. Warrant (PKBOW) in Q4 2022, closing a stake of 15,782 shares — an estimated $2K sold.

Citadel Advisors first reported a position in PKBOW in Q1 2021 and held it in 7 quarters. The position peaked at $48K in Q1 2021. 15 funds tracked by Wall St. Rank hold PKBOW as of Q4 2022.

Citadel Advisors reported no remaining Peak Bio, Inc. Warrant position as of Q4 2022 after selling out during the quarter.
Citadel Advisors sold 15,782 Peak Bio, Inc. Warrant shares in Q4 2022, an estimated $2K.
Citadel Advisors first reported a position in Peak Bio, Inc. Warrant in Q1 2021 and held it in 7 quarters.
Citadel Advisors's Peak Bio, Inc. Warrant position peaked at $48K in Q1 2021.
15 funds tracked by Wall St. Rank held Peak Bio, Inc. Warrant as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.